EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions

Giuseppe Tarantini, Gilbert H L Tang, Thomas Pilgrim, Won-K Kim, Adam Greenbaum, Fausto Castriota, John G Webb, Luis Nombela Franco, Ole De Backer, Tau Hartikainen, Pablo Codner, Ofir Koren und 11 weitere

JACC: Cardiovascular Interventions · 2025-01 · 18 (1) · 103-115

DOI: 10.1016/j.jcin.2024.10.037 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-01. Verfasst von Giuseppe Tarantini und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy. Electronic address: giuseppe.tarantini.1@gma…. Hauptthemen laut MEDLINE: Aortic Valve, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation, Aortic Valve Stenosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lifetime treatment of aortic valve disease is a matter of increasing debate. Although the risks of a second aortic valve intervention are recognized, little attention has been given to the challenges of a third. OBJECTIVES: This study delves into the clinical characteristics, indications, and outcomes of patients undergoing 3 aortic valve interventions. METHODS: The THIRD (THree aortIc Reinterventions for valve Disease) registry is a retrospective multicenter, international study of patients who underwent a third procedure on the aortic valve, either surgically or transcatheter-based. Patients undergoing 2 aortic procedures during the same hospital admission were excluded. Baseline characteristics, timing, and mode of bioprosthetic failure, sequence of the procedures, and clinical outcomes were adjudicated according to the Valve Academic Research Consortium criteria. RESULTS: A total of 51 patients from 11 centers were enrolled in this study. Median follow-up time was 565 (314-1,560) days. Eighteen patients (35%) underwent surgical aortic valve replacement (SAVR), and 33 of 51 patients (65%) underwent transcatheter aortic valve replacement (TAVR) as the third intervention. Mean age was 69 ± 14 years, 20 of 51 patients (39%) were female. STS score was 5.0% (Q1-Q3: 3.3%-7.0%). In all TAVR cases, the indication for the first intervention was severe aortic stenosis, as was the indication in 31 of 45 (69%) of SAVR cases (33% bicuspid). The most prevalent procedure sequence was SAVR-SAVR-TAVR (19/51, 37%), followed by SAVR-SAVR-SAVR (10/51, 20%) and SAVR-TAVR-TAVR (10/51, 20%). TAVR-TAVR-TAVR was performed in 4 of 51 cases (8%). The primary indications for a third intervention included structural valve deterioration (SVD) (39/51, 76%), non-SVD (8/51, 16%), and endocarditis (2/51, 4%). Excluding patients with a mechanical prosthesis, predictors of SAVR as third intervention included a lower STS score (OR: 0.58; 95% CI: 0.34-0.98; P = 0.04) and the presence of moderate or severe prosthesis-patient mismatch (OR: 44.8; 95% CI: 2.41-122.00; P = 0.01). Thirty-day device success was 85% for TAVR and 94% for SAVR. CONCLUSIONS: In the THIRD registry, SVD emerged as the predominant indication for a third aortic valve procedure. The most frequent procedure sequence was SAVR-SAVR-TAVR, whereas TAVR-TAVR-TAVR was less common. Although the short-term outcomes in our selected cohort were favorable, further investigation is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveTranscatheter Aortic Valve ReplacementHeart Valve Prosthesis ImplantationAortic Valve StenosisHumansFemaleRegistriesMaleAgedRetrospective StudiesTreatment OutcomeTime FactorsRisk FactorsAged, 80 and overMiddle AgedHeart Valve ProsthesisBioprosthesisReoperationProsthesis FailureEuropeRecovery of FunctionSeverity of Illness Index

Stichwörter der Autor:innen

aortic stenosislifetime strategyredo transcatheter aortic valve replacementsurgical aortic valve replacementtranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy. Electronic address: giuseppe.tarantini.1@gmail.com.
  • Department of Cardiovascular Surgery, Mount Sinai Health System, New York, New York, USA.
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Rhein/Main, Kerckhoff Heart Center, Department of Cardiac Surgery, Bad Nauheim, Germ…
  • Division of Cardiology, Emory Structural Heart and Valve Center, Emory University Hospital Midtown, Atlanta, Georgia, USA.
  • Maria Cecilia Hospital GVM Care & Research, Cotignola, Italy.

Zitieren

APA

Tarantini, G., Tang, G. H. L., Pilgrim, T., Kim, W. K., Greenbaum, A., Castriota, F., Webb, J. G., Nombela Franco, L., De Backer, O., Hartikainen, T., Codner, P., Koren, O., Patel, V., Meier, D., Tomii, D., Ueyama, H. A., Paredes-Vázquez, J. G., Arturi, F., Kornowski, R., …, & THIRD Registry Investigators (2025). Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions. JACC: Cardiovascular Interventions, 18(1), 103-115. https://doi.org/10.1016/j.jcin.2024.10.037

Vancouver

Tarantini G, Tang GHL, Pilgrim T, Kim WK, Greenbaum A, Castriota F, et al. Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions. JACC: Cardiovascular Interventions. 2025;18(1):103-115. doi:10.1016/j.jcin.2024.10.037

BibTeX
@article{Tarantini2025,
  author = {Tarantini, Giuseppe and Tang, Gilbert H L and Pilgrim, Thomas and Kim, Won-K and Greenbaum, Adam and Castriota, Fausto and Webb, John G and Nombela Franco, Luis and De Backer, Ole and Hartikainen, Tau and Codner, Pablo and Koren, Ofir and Patel, Vivek and Meier, David and Tomii, Daijiro and Ueyama, Hiroki A and Paredes-Vázquez, José Gildardo and Arturi, Federico and Kornowski, Ran and Makkar, Raj R and Cardaioli, Francesco and Nai Fovino, Luca and THIRD Registry Investigators, THIRD Registry Investigators},
  title = {Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {103--115},
  doi = {10.1016/j.jcin.2024.10.037}
}
Kostenlos starten →